Search for a Medicine

  • Medicines
 
 

Showing 21-40 of 800 matching medicines

Product listings were last updated on 08/12/2023
Trade Name Licence Number & Holder Documents
Palexia SR 100 mg prolonged-release tablets
Prolonged-release tablet

Compare
PPA0465/458/003
Authorised: 04/12/2020
PCO Manufacturing Ltd.
SPC PIL
Palexia SR 150 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA2242/012/006
Authorised: 21/12/2010
Grunenthal Pharma Ltd
SPC PIL
Palexia SR 200 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA2242/012/007
Authorised: 21/12/2010
Grunenthal Pharma Ltd
SPC PIL
PALEXIA SR 25 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA2242/012/009
Authorised: 25/05/2012
Grunenthal Pharma Ltd
SPC PIL
Palexia SR 250 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA2242/012/008
Authorised: 21/12/2010
Grunenthal Pharma Ltd
SPC PIL
Palexia SR 50 mg prolonged-release tablets
Prolonged-release tablet

Compare
PA2242/012/004
Authorised: 21/12/2010
Grunenthal Pharma Ltd
SPC PIL
Palexia SR 50 mg prolonged-release tablets
Prolonged-release tablet

Compare
PPA0465/458/002
Authorised: 11/12/2020
PCO Manufacturing Ltd.
SPC PIL
Palforzia
Oral powder in capsules for opening

Compare
EU/1/20/1495/001
Authorised: 17/12/2020
Aimmune Therapeutics Netherlands B.V.
SPC PIL IPAR EdM
Palforzia
Oral powder in capsules for opening

Compare
EU/1/20/1495/002-003
Authorised: 17/12/2020
Aimmune Therapeutics Netherlands B.V.
SPC PIL IPAR EdM
Palforzia
Oral powder in capsules for opening

Compare
EU/1/20/1495/004
Authorised: 17/12/2020
Aimmune Therapeutics Netherlands B.V.
SPC PIL IPAR EdM
Palforzia
Oral powder in capsules for opening

Compare
EU/1/20/1495/005-010
Authorised: 17/12/2020
Aimmune Therapeutics Netherlands B.V.
SPC PIL IPAR EdM
Palforzia
Oral powder in capsules for opening

Compare
EU/1/20/1495/011
Authorised: 17/12/2020
Aimmune Therapeutics Netherlands B.V.
SPC PIL IPAR EdM
Palforzia
Oral powder in sachet

Compare
EU/1/20/1495/012-013
Authorised: 17/12/2020
Aimmune Therapeutics Netherlands B.V.
SPC PIL IPAR EdM
Paliperidone
Prolonged-release solution for injection

Compare
EU/1/14/971/001
Authorised: 05/12/2014
Janssen-Cilag International NV
SPC PIL IPAR
Paliperidone
Prolonged-release solution for injection

Compare
EU/1/14/971/002
Authorised: 05/12/2014
Janssen-Cilag International NV
SPC PIL IPAR
Paliperidone
Prolonged-release solution for injection

Compare
EU/1/14/971/003
Authorised: 05/12/2014
Janssen-Cilag International NV
SPC PIL IPAR
Paliperidone
Prolonged-release solution for injection

Compare
EU/1/14/971/004
Authorised: 05/12/2014
Janssen-Cilag International NV
SPC PIL IPAR
Paliperidone
Prolonged-release solution for injection

Compare
EU/1/14/971/005
Authorised: 05/12/2014
Janssen-Cilag International NV
SPC PIL IPAR
Paliperidone Janssen
Prolonged-release solution for injection

Compare
EU/1/14/971/006
Authorised: 05/12/2014
Janssen-Cilag International NV
SPC PIL IPAR
Paliperidone Janssen-Cilag International
Prolonged-release suspension for injection

Compare
EU/1/20/1453/001
Authorised: 18/06/2020
Janssen Pharmaceutica NV
SPC PIL IPAR